This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2017 Remove Medical science Remove Physicians
article thumbnail

Progressing personalised cell therapies in oncology

European Pharmaceutical Review

MAY 23, 2024

In this Q&A, Dr Imran Khan, PhD, Vice President Medical Affairs, Hematology at Johnson & Johnson Innovative Medicine, highlights the current landscape of CAR T therapies such as CARVYKTI and touches on the future direction of the sector. Most recently, Imran has served as Medical Science Liaison (MSL) Head, Oncology U.S.

Food and Drug Administration 110
Food and Drug Administration Food Medical Medicine 110
article thumbnail

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Medgadget

MARCH 2, 2023

To make implantation of the Alpha DaRT sources easy and precise, the company developed dedicated applicators andadapted existing biopsy devices, that physicians are already acquainted with, to deliver the radioactive sources. Results from initial clinical trials were quite impressive. More info can be found at the Biomed Israel website.

Manufacturing 82
Manufacturing Leads Patients Medicine 82
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
Webinars
About
Editions
Webinars
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024